Related Experiment Video
Updated: Jun 23, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
Microbiota and mycobiota in chronic inflammatory demyelinating polyneuropathy: clinical and pathophysiological
Szymon Andrusiów1, Anita Brzoza2, Piotr Łacina3
1Department of Neurology, Faculty of Medicine, University Centre of Neurology and Neurosurgery, Wrocław Medical University, Wrocław, Poland.
Introduction:
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune mediated neuropathy with incompletely defined triggers and no validated biomarkers. We investigated associations between bacterial and fungal communities, short chain fatty acids (SCFAs), and IL18 promoter variation with clinically/electrophysiologically relevant measures.
Methods:
We enrolled 32 treatment naive CIDP patients and 15 healthy controls. Stool, serum and cerebrospinal fluid (CSF) samples were collected. Disability was assessed using the clinical scale and related to nerve conduction study (NCS) parameters. IL18 promoter variants (rs187238, rs1946518, and rs1946519) were genotyped in haplotype based comparisons. SCFAs were quantified in stool, serum, and CSF. Faecal and CSF microbiota and mycobiota were profiled by amplicon sequencing of the 16S rRNA V3 V4 region and the ITS1 region, respectively. Bioinformatic processing and diversity analyses were performed in QIIME2. Alpha diversity and beta diversity metrics were computed across taxonomic levels. Differential abundance testing was conducted with ANCOM BC2.
Results:
CIDP was characterised by increased faecal bacterial alpha diversity and significant shifts in beta diversity relative to controls. Diversity patterns differed across clinical subgroups, including diabetes status and disability severity. Higher faecal bacterial diversity metrics correlated with greater NCS abnormalities, whereas associations with beta diversity measures were weaker. Taxonomic analyses identified enrichment of Hominisplanchenecus_A faecis and depletion of Lawsonibacter sp000177015 in CIDP. SCFAs concentrations correlated with bacterial diversity indices, and IL18 haplotypes were associated with distinct microbial signatures. Faecal mycobiota showed no robust case control differences in overall diversity. CSF sequencing revealed a low biomass bacterial signal and diversity metrics correlated with neurophysiological measures.
Discussion:
We confirmed the increased gut microbiome alpha diversity in CIDP patients, as observed in previous research. Our findings suggest significant alterations in both gut microbiota and mycobiota during the course of CIDP, which correlate with clinical, electrophysiological, and laboratory parameters.
Insights
This study found increased gut bacteria diversity in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients, correlating with disease severity and nerve damage. Microbiome and fungal alterations were observed, offering potential new biomarkers for CIDP.
Area of Science:
- Neurology
- Microbiology
- Immunology
Background:
- Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated neuropathy with unknown triggers and no validated biomarkers.
- Investigating the gut microbiome and its relationship with immune responses is crucial for understanding CIDP pathogenesis.
Purpose of the Study:
- To investigate associations between bacterial and fungal communities, short-chain fatty acids (SCFAs), and IL18 promoter variation in CIDP patients.
- To correlate these factors with clinical and electrophysiological measures of disease severity.
Main Methods:
- 32 treatment-naive CIDP patients and 15 healthy controls were enrolled.
- Stool, serum, and cerebrospinal fluid (CSF) samples were analyzed for microbiota, mycobiota, and SCFAs.
- IL18 promoter variants were genotyped, and disability was assessed using clinical scales and nerve conduction studies (NCS).
Main Results:
- CIDP patients exhibited increased fecal bacterial alpha diversity and significant beta diversity shifts compared to controls.
- Higher fecal bacterial diversity correlated with greater NCS abnormalities.
- Specific bacterial taxa were enriched or depleted in CIDP, and SCFA concentrations correlated with bacterial diversity.
Conclusions:
- The study confirms increased gut microbiome alpha diversity in CIDP patients.
- Significant alterations in gut microbiota and mycobiota are associated with CIDP and correlate with clinical and electrophysiological parameters.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Dysbiosis of the Gut Microbiota
Fungal Phylum Microsporidia
Inflammatory Bowel Disease II: Ulcerative Colitis
Chronic Pancreatitis II: Pathophysiology
